Loading data
RBBNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 844.56 m USD | 833.88 m USD | 826.34 m USD | 819.76 m USD | 844.96 m USD |
| Cost of revenue | 423.85 m USD | 394.37 m USD | 418.26 m USD | 418.82 m USD | 400.3 m USD |
| Gross profit | 420.71 m USD | 439.51 m USD | 408.08 m USD | 400.94 m USD | 444.66 m USD |
| Research and development expense | 178.87 m USD | 179.94 m USD | 190.66 m USD | 203.68 m USD | 194.95 m USD |
| Operating profit | -3.32 m USD | 16.87 m USD | -24.29 m USD | -48.32 m USD | -117.8 m USD |
| Profit before tax | -45.11 m USD | -46.07 m USD | -55.37 m USD | -112.6 m USD | -208.14 m USD |
| Income tax expense | -84.75 m USD | 8.17 m USD | 10.83 m USD | -14.52 m USD | -30.96 m USD |
| Net income (reported basis) | 39.64 k USD | -54.24 k USD | -66.21 k USD | -98.08 k USD | -177.19 k USD |
| Net income attributable to common shareholders | — | — | — | — | -177.19 m USD |
| Basic earnings per share | 0.22 USD/share | -0.31 USD/share | -0.39 USD/share | -0.63 USD/share | -1.2 USD/share |
| Diluted earnings per share | 0.22 USD/share | -0.31 USD/share | -0.39 USD/share | -0.63 USD/share | -1.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.